Revenue: The sum of all revenue fields included for a company's operating activities.
Solid Biosciences Inc. (SLDB) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
Revenue |
-- |
$-39.28M |
|
-- |
|
-- |
|
$40.05M |
|
$-40.05M |
|
$0.77M |
|
$-39.28M |
|
$-39.28M |
|
$-39.28M |
|
$-39.28M |
|
$-39.28M |
|
$-39.28M |
|
$-40.05M |
|
$-39.96M |
|
66.34M |
|
66.34M |
|
$-0.59 |
|
$-0.59 |
|
Balance Sheet Financials | |
$313.41M |
|
$4.48M |
|
$30.50M |
|
$343.90M |
|
$28.78M |
|
-- |
|
$20.66M |
|
$49.44M |
|
$294.46M |
|
$294.46M |
|
$294.46M |
|
77.49M |
|
Cash Flow Statement Financials | |
$-31.85M |
|
$-27.46M |
|
$189.73M |
|
$82.19M |
|
$212.60M |
|
$130.41M |
|
$3.34M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
10.89 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.34% |
|
-13.34% |
|
-11.42% |
|
-13.34% |
|
$3.80 |
|
$-0.48 |
|
$-0.48 |